scispace - formally typeset
A

Alastair M. Thompson

Researcher at Baylor College of Medicine

Publications -  446
Citations -  22855

Alastair M. Thompson is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 67, co-authored 361 publications receiving 18367 citations. Previous affiliations of Alastair M. Thompson include University of Texas MD Anderson Cancer Center & University of Dundee.

Papers
More filters
Journal ArticleDOI

Telomere reduction in human colorectal carcinoma and with ageing

TL;DR: It is shown that in most of the colorectal carcinomas that were analysed, there is a reduction in the length of telomere repeat arrays relative to the normal colonic mucosa from the same patient, and it is proposed that the telomerase2–4 is inactive in somatic tissues, andTelomere length is an indicator of the number of cell divisions that it has taken to form a particular tissue and possibly to generate tumours.
Journal ArticleDOI

Pan-cancer analysis of whole genomes

Peter J. Campbell, +1332 more
- 06 Feb 2020 - 
TL;DR: The flagship paper of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium describes the generation of the integrative analyses of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types, the structures for international data sharing and standardized analyses, and the main scientific findings from across the consortium studies.
Journal ArticleDOI

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

TL;DR: Among women with early-stage breast cancer who were at high clinical risk and low genomic risk for recurrence, the receipt of no chemotherapy on the basis of the 70-gene signature led to a 5-year rate of survival without distant metastasis that was 1.5 percentage points lower than the rate with chemotherapy.
Journal ArticleDOI

The p53 tumour suppressor gene

TL;DR: Current understanding of the p53 tumour suppressor gene function and potential clinical significance is reviewed.
Journal ArticleDOI

Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator

TL;DR: It is shown that tenovins act through inhibition of the protein-deacetylating activities of SirT1 and SirT2, two important members of the sirtuin family, and underscores the utility of these compounds as biological tools for the study of sIRTuin function as well as their potential therapeutic interest.